Vaks Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 23 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.80 M
- Revenue Growth 40.13%
- Profit Growth 21.34%
- Ebitda 1494.29%
- Net Worth 13.67%
- Total Assets 61.07%
About Vaks Pharma
Vaks Pharma Private Limited (VPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 24 October 2001 and has a history of 23 years and three months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.80 M.
Siddharth Panikar and Arjun Panikar serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U51397MH2001PTC133776
- Company No.
133776
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Oct 2001
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Vaks Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arjun Panikar  | Director | 21-Aug-2018 | Current |
| Siddharth Panikar | Director | 20-Jul-2007 | Current |
Financial Performance of Vaks Pharma.
Vaks Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 40.13% increase. The company also saw a substantial improvement in profitability, with a 21.34% increase in profit. The company's net worth Soared by an impressive increase of 13.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vaks Pharma?
Unlock access to Vaks Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Mitoch Pharma Private LimitedSiddharth Panikar and Arjun Panikar are mutual person
Mccoy Pharma Private LimitedSiddharth Panikar and Arjun Panikar are mutual person
Sheerdrive Private LimitedSiddharth Panikar is a mutual person
P. N. Packaging Private LimitedSiddharth Panikar is a mutual person
Charges (Loans)
₹3.80 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.38 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Apr 2024 | Others | ₹3.80 M | Open |
How Many Employees Work at Vaks Pharma?
Unlock and access historical data on people associated with Vaks Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vaks Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vaks Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
